Prophylactic intraoperative uterine artery embolization for the management of major placenta previa. (2nd September 2022)

• Record Type: Journal Article
• Authors: Radaelli, Tatjana; Ferrari, Maria M.; Duiella, Silvia F.; Gazzola, Federica G.; Campoleoni, Mauro; Merlini, Claudia; Martinetti, Laura; Ambrosini, Maria T.; Ossola, Manuela W.; Nicolini, Antonio
• Is Part Of: Journal of maternal-fetal & neonatal medicine. Volume 35:Number 17(2022)
• Page Start: 3359
• Page End: 3364
• Publication Date: 2022-09-02
• Subjects: Placenta previa -- uterine artery embolization -- prophylactic embolization -- post partum hysterectomy; Obstetrics -- Periodicals; Perinatology -- Periodicals; Infants (Newborn) -- Diseases -- Periodicals; Neonatology -- Periodicals; 618.2
• DOI: 10.1080/14767058.2020.1818218
• Languages: English
• ISSNs: 1476-7058

Abstract

Abstract: Purpose: Placenta previa is a major cause of maternal morbidity and mortality, associated to a high risk of peripartum hemorrhage and hysterectomy. We aimed to verify if prophylactic intraoperative uterine artery embolization in patients with placenta previa and at least one additional risk of bleeding (major placenta previa), can reduce hemorrhage, need for blood transfusions, peripartum hysterectomy and maternal morbidity. Materials and methods: We enrolled 76 patients with major placenta previa; a specific multidisciplinary protocol was designed for management, including ultrasound evaluation, hospitalization at 34 weeks, antenatal corticosteroids and scheduled cesarean section at 35–36 weeks. 44 patients (control group or CTR) were treated with elective cesarean section, 32 patients (embolized group or EMB) underwent selective catheterization of bilateral uterine arteries before cesarean section and subsequent uterine embolization. In both cases cesarean section was performed by a senior surgeon. Results: Significant differences were found in term of intraoperative blood loss (CTR: 1431 ml; EMB: 693 ml); despite an high percentage of CTR patients had a bleeding greater than 1000 ml (56%), the need for blood transfusion was not significantly different between the two groups. Time of surgery was higher in the EMB group, considering that embolization procedure required approximatively 30 min. Three patients from the CTR group needed hysterectomy and ICU admission, compared to none in the EMB group. Duration of hospitalization and neonatal outcome were similar. Uterine embolization was not related to any short or long-term complications; return to normal menses and preservation of fertility were confirmed at follow up. Conclusions: Our results are promising, although we believe that a major contribution is referable to the multidisciplinary approach rather than the procedure itself. Nevertheless, we demonstrated the feasibility and safety of preventive uterine embolization in patients with placenta previa; in order to establish its prophylactic role in the prevention of peripartum hemorrhage, randomized trial should be carried out, on a larger population.